Neobe Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.36M

  • Investors
  • 14

Neobe General Information

Description

Developer of a synthetic biology platform designed to promote therapeutic efficacy in patients with solid tumors. The company's platform creates a programmable bacteria that alters the microenvironment of solid tumors from within by locally breaking down stromal barriers which increases immune cell and drug infiltration and helps to avoid systemic toxicities while increasing efficacy, enabling patients to respond to immunotherapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Salisbury House
  • Station Road
  • Cambridge CB1 2LA
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Corporate Office
  • Salisbury House
  • Station Road
  • Cambridge CB1 2LA
  • England, United Kingdom

Neobe Timeline

2022202320242025
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neobe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Seed Round 22-Dec-2023 $2.36M Completed Pre-Clinical Trials
9. Accelerator/Incubator Completed Pre-Clinical Trials
8. Accelerator/Incubator Completed Pre-Clinical Trials
7. Grant Completed Pre-Clinical Trials
6. Accelerator/Incubator 14-Jun-2023 Completed Product In Beta Test
5. Seed Round 23-Nov-2022 Completed Product In Beta Test
4. Grant 01-May-2022 Completed Product In Beta Test
3. Accelerator/Incubator 28-Sep-2021 Completed Product In Beta Test
2. Seed Round 12-Mar-2021 $195K $195K Completed Generating Revenue
1. Accelerator/Incubator 20-Jan-2021 Completed Generating Revenue
To view Neobe’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Neobe Patents

Neobe Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202311258-D0 Methods and compostions Pending 21-Jul-2023

Neobe Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neobe Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
2048 Ventures Venture Capital Minority
Pioneer Group (London) Venture Capital Minority
Creative Destruction Lab Accelerator/Incubator
Discovery Park Ventures Family Office Minority
Angel (individual) Minority
You’re viewing 5 of 14 investors. Get the full list »

Neobe FAQs

  • When was Neobe founded?

    Neobe was founded in 2021.

  • Where is Neobe headquartered?

    Neobe is headquartered in Cambridge, United Kingdom.

  • What is the size of Neobe?

    Neobe has 10 total employees.

  • What industry is Neobe in?

    Neobe’s primary industry is Biotechnology.

  • Is Neobe a private or public company?

    Neobe is a Private company.

  • What is Neobe’s current revenue?

    The current revenue for Neobe is .

  • How much funding has Neobe raised over time?

    Neobe has raised $2.86M.

  • Who are Neobe’s investors?

    2048 Ventures, Pioneer Group (London), Creative Destruction Lab, Discovery Park Ventures, and are 5 of 14 investors who have invested in Neobe.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »